Journal article icon

Journal article

Mezigdomide combined with bortezomib disrupts the cell cycle and elicits superior antitumor effects in multiple myeloma

Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1016/j.bneo.2025.100179

Authors


Publisher:
Elsevier
Journal:
Blood Neoplasia More from this journal
Volume:
3
Issue:
1
Publication date:
2025-11-07
Acceptance date:
2025-09-29
DOI:
EISSN:
2950-3280
ISSN:
2950-3280


Language:
English
Source identifiers:
3743478
Deposit date:
2026-02-10
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP